Treatment-related adverse events (TRAEs) of possible or likely attribution to study therapies for enrolled population (n=9)
| Toxicity | Grade 1–2 n (%) | Grade 3–5 n (%) |
| Rash | 3 (33) | 1 (11) |
| Pruritus | 1 (11) | 1 (11) |
| Fatigue | 2 (22) | 0 |
| ARDS | 0 | 1 (11)*† |
| Headache | 0 | 1 (11) |
| Pneumonitis | 0 | 1 (11)* |
| Abdominal pain | 1 (11) | 0 |
| Arthralgia | 1 (11) | 0 |
| Diarrhea | 1 (11) | 0 |
| Fever | 1 (11) | 0 |
| Hypothyroidism | 1 (11) | 0 |
| Infusion reaction | 1 (11) | 0 |
| Nausea | 1 (11) | 0 |
| Psoriasis | 1 (11) | 0 |
*Suspected to be more likely related to post-surgical complications but coded as “possibly related” TRAEs to be conservative.
†Grade 5 TRAE; all other grade 3–5 TRAEs were grade 3.
ARDS, acute respiratory distress syndrome; TRAE, treatment-related adverse event.